IRIS UniCatt

Lopetuso, Loris Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.271
AS - Asia 4.785
EU - Europa 4.090
SA - Sud America 969
Continente sconosciuto - Info sul continente non disponibili 272
AF - Africa 123
OC - Oceania 6
Totale 17.516
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.008
SG - Singapore 2.232
CN - Cina 1.080
IT - Italia 963
BR - Brasile 785
SE - Svezia 768
DE - Germania 733
FR - Francia 447
VN - Vietnam 419
IE - Irlanda 217
GB - Regno Unito 214
IN - India 159
FI - Finlandia 155
ID - Indonesia 142
UA - Ucraina 137
JP - Giappone 134
BD - Bangladesh 130
CA - Canada 125
PL - Polonia 123
HK - Hong Kong 118
RU - Federazione Russa 87
MX - Messico 78
TR - Turchia 75
AR - Argentina 72
KR - Corea 47
NL - Olanda 45
ZA - Sudafrica 45
IQ - Iraq 40
ES - Italia 36
BE - Belgio 34
EC - Ecuador 30
IR - Iran 28
CO - Colombia 21
JM - Giamaica 21
PK - Pakistan 21
SA - Arabia Saudita 21
UZ - Uzbekistan 18
EG - Egitto 17
CL - Cile 15
VE - Venezuela 15
AT - Austria 14
AZ - Azerbaigian 13
AE - Emirati Arabi Uniti 12
CZ - Repubblica Ceca 12
KE - Kenya 11
NP - Nepal 11
PE - Perù 11
RO - Romania 11
CI - Costa d'Avorio 10
EU - Europa 10
JO - Giordania 10
LT - Lituania 10
MA - Marocco 10
PH - Filippine 10
PY - Paraguay 9
TN - Tunisia 9
CH - Svizzera 8
CR - Costa Rica 8
BG - Bulgaria 7
GR - Grecia 7
MY - Malesia 7
OM - Oman 7
RS - Serbia 7
TT - Trinidad e Tobago 7
AL - Albania 6
DZ - Algeria 6
IL - Israele 6
TH - Thailandia 6
TW - Taiwan 6
BH - Bahrain 5
HN - Honduras 5
HR - Croazia 5
HU - Ungheria 5
LV - Lettonia 5
UY - Uruguay 5
AU - Australia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
NO - Norvegia 4
PT - Portogallo 4
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
EE - Estonia 3
KG - Kirghizistan 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
PS - Palestinian Territory 3
SI - Slovenia 3
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
BY - Bielorussia 2
GT - Guatemala 2
GY - Guiana 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
LI - Liechtenstein 2
Totale 17.217
Salva come PNG Salva come JPEG
Città #
Singapore 1.277
Chandler 817
Ashburn 749
San Jose 651
Beijing 293
New York 210
Dublin 207
Los Angeles 202
Rome 149
Ho Chi Minh City 141
Lauterbourg 127
Jakarta 124
Tokyo 121
Cattolica 114
Hanoi 113
Boston 109
Dallas 106
Hong Kong 100
Milan 99
The Dalles 96
Ann Arbor 93
Warsaw 91
San Mateo 90
Hefei 88
Wilmington 87
Jacksonville 86
Munich 86
Frankfurt am Main 85
São Paulo 77
Council Bluffs 76
Princeton 73
Fairfield 71
Nanjing 70
Helsinki 69
Houston 69
Santa Clara 69
Marseille 61
Seattle 56
Atlanta 55
Chicago 55
Woodbridge 54
Moscow 52
Dearborn 50
Hangzhou 47
Boardman 45
London 43
Redwood City 42
Izmir 39
Nuremberg 35
Phoenix 35
Seoul 35
Buffalo 34
Montreal 34
Shanghai 34
North Bergen 32
Stockholm 32
Denver 31
St Louis 31
Brussels 30
Chennai 30
Guangzhou 30
Brooklyn 29
Orem 29
Lawrence 28
San Francisco 28
Turku 28
Bremen 27
Johannesburg 27
Lappeenranta 27
Augusta 25
Da Nang 24
Paris 24
Rio de Janeiro 24
Toronto 24
Shenyang 23
Tianjin 23
Kent 22
Memphis 22
Poplar 22
Pune 22
Lancaster 21
Nürnberg 21
Redmond 21
Mexico City 20
Andover 19
Haiphong 19
Nanchang 19
Amsterdam 18
Belo Horizonte 18
Florence 18
Baghdad 17
Cambridge 17
Manchester 17
Norwalk 17
Hyderabad 16
Jiaxing 16
Kraków 16
Guayaquil 15
Hebei 15
Curitiba 14
Totale 8.939
Salva come PNG Salva come JPEG
Nome #
Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin 385
Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition. 360
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 324
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 292
When to Perform a Colonoscopy in Diverticular Disease and Why: A Personalized Approach 270
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 239
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease 215
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 212
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 211
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 209
The gut barrier: new acquisitions and therapeutic approaches 201
Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel 199
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review 197
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 194
13C-octanoic acid breath test to study gastric emptying time 188
Federated learning in inflammatory bowel disease: The future of privacy-preserving Artificial Intelligence 183
Skeletal muscle-gut axis: Emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases 179
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD? 176
Actinobacteria: A relevant minority for the maintenance of gut homeostasis 170
Solute Transporter OCTN1/Slc22a4 Affects Disease Severity and Response to Infliximab in Experimental Colitis: Role of Gut Microbiota and Immune Modulation 169
Dysbiosis, gut microbiota modulation and intestinal permeability in recurrent cystitis patients and concomitant gastrointestinal pathologies 167
The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors 163
The gastrointestinal microbiome - functional interference between stomach and intestine 162
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 162
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients 160
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 158
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 156
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 156
Development and validation of predictive assessment of complicated diverticulitis score 156
The use of probiotics in different phases of diverticular disease 155
Digital integration between hospitals and local health authorities for enhanced vaccination coverage among frail patients: the CareVax study protocol 154
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 153
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 152
Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools 150
Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation 147
MOREOVER: multiomics MR-guided radiotherapy optimization in locally advanced rectal cancer 147
Bacillus clausii and gut homeostasis: state of the art and future perspectives 146
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? 144
Role of yeasts in healthy and impaired gut microbiota: the gut mycome 143
Gut microbial flora, prebiotics and probiotics in IBD: their current usage and utility 142
Microbes and Alzheimer' disease: Lessons from H. Pylori and GUT microbiota 140
Endoscopic Management of Strictures in Crohn’s Disease: An Unsolved Case 137
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 137
Gut microbiota profiling and gut-brain crosstalk in children affected by pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections 137
Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19 136
Assessment of small intestinal bacterial overgrowth and methane production in patients on chronic proton-pump inhibitor treatment: prevalence and role of rifaximin in its management in primary care 135
Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease 134
Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders 134
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 134
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 133
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats 132
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 132
Commensal Clostridia: leading players in the maintenance of gut homeostasis 131
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 131
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center 131
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 129
Microbiota Composition in Diverticular Disease: Implications for Therapy 123
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 123
Gut microbiota and inflammatory bowel disease: an update 123
Knowledge of Diagnostic and Therapeutic Aspects of IBD Among Nurses Working in Digestive Endoscopy: A Nationwide Italian Survey 123
A modern multidisciplinary approach to the treatment of enterocutaneous fistulas in Crohn’s disease patients 123
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease 122
Can we predict the efficacy of anti-TNF-α agents? 122
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The “EPIMICI – San Marino” study 120
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 120
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment 120
A transition clinic model for inflammatory bowel disease between two tertiary care centers: outcomes and predictive factors 118
Considering gut microbiota disturbance in the management of Helicobacter pylori infection 117
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 117
Radiomics could predict surgery at 10 years in Crohn's disease 115
Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period 114
Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis 113
Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities 113
Intestinal inflammation and microbiota modulation impact cochlear function: emerging insights in gut-ear axis 111
How to face the advent of sars-cov-2 vaccination in ibd patients: Another task for gastroenterologists 111
Impact of the Trophic Effects of the Secretome from a Multistrain Probiotic Preparation on the Intestinal Epithelia 111
Changes in the intestinal microbiota in patients with a major depressive episode and ulcerative colitis 110
Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals 110
Secretome modulation of Caco-2 cell line induced by a multi-strain probiotic 110
Bacillus clausii for the treatment of acute diarrhea in children: A systematic review and meta-analysis of randomized controlled trials 108
Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase 108
Infliximab does not increase colonic cancer risk associated to murine chronic colitis 105
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma 105
Microbiota Composition in Diverticular Disease: Implications for Therapy 103
Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase 101
Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach 100
The “dica” endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists 100
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions 99
Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches 99
Driving scientific progress and shaping the future of gastroenterology: a new start for our Journal, between innovation, growth and multidisciplinarity 98
Gut Virome and Inflammatory Bowel Disease 98
Coeliac disease under a microscope: Histological diagnostic features and confounding factors 98
Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases 97
Gut microbiota during dietary restrictions: New insights in non-communicable diseases 97
Human herpesvirus 8-associated colonic Kaposi's sarcoma during vedolizumab treatment in ulcerative colitis: A case report and review of the literature 97
Relationship between oral microbiota and periodontal disease: a systematic review 96
[Ulcerative colitis] 95
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: An update 94
Assessment of Crohn's Disease Activity: Magnetic Resonance Enterography in Comparison with Clinical and Endoscopic Evaluations 93
Prevalence of cervical HPV and attitude towards cervical screening in IBD patients under immunomodulatory treatment: A multidisciplinary management experience 93
Totale 14.562
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.839
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.839
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022821 0 0 23 66 70 25 12 135 48 94 180 168
2022/20232.198 311 305 164 346 135 248 103 176 239 35 75 61
2023/20241.220 76 313 54 74 42 171 79 49 54 43 123 142
2024/20252.476 59 74 206 61 179 84 118 103 328 292 518 454
2025/20266.923 985 194 388 864 1.232 364 1.093 345 501 470 234 253
2026/20271.370 324 1.022 24 0 0 0 0 0 0 0 0 0
Totale 17.516